PUBLIC COMPANY
saveBAUSCH AND LOMB
USupdated 3mo ago
community read0 votes
pipeline
8
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(8)
pipeline depth8 products
8Unknown
drug
BACITRACIN ZINC AND POLYMYXIN B SULFATE
drugEYE ALLERGY RELIEF
drugNEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
drugNEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
drugNEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE
drugNEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE
drugSULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
drugTOBRAMYCIN AND DEXAMETHASONE
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- FDA warns Bausch and Lomb, Indian API maker for GMP issuesThe US Food and Drug Administration (FDA) recently issued warning letters to ophthalmic product maker Bausch and Lomb and an Indian active pharmaceutical ingredient (API) maker for violations of go…raps · 6d ago
comments(0)
5-min edit window · permanent after that